References
Black D and
Rosen CJ
(2006)
Bisphosphonates for the prevention and treatment of osteoporosis. In:
Favus MJ (ed.)
Osteoporosis, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism,
6th edn,
pp. 277–283.
Washington, DC:
ASBMR Press.
Dawson‐Hughes B
(2006)
Calcium and Vitamin‐D. In:
Favus MJ (ed.)
Osteoporosis, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism,
6th edn,
pp. 257–259.
Washington, DC:
ASBMR Press.
Ferrari SL and
Rizzoli R
(2005)
Gene variants for osteoporosis and their pleiotropic effects in aging.
Molecular Aspects of Medicine
26: 145–167.
Harvey N,
Earl S and
Cooper C
(2006)
Epidemiology of osteoporotic fractures. In:
Favus MJ (ed.)
Osteoporosis, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism,
6th edn,
pp. 244–248.
Washington, DC:
ASBMR Press.
Marcus R
(2001)
Role of exercise in preventing and treating osteoporosis.
Rheumatic Diseases Clinics of North America
27: 131–141.
Melzer K,
Kayser B and
Pichard C
(2004)
Physical activity: the health benefits outweigh the risks.
Current Opinion in Clinical Nutrition and Metabolic Care
7: 641–647.
Mundy GR,
Oyajobi B,
Traianedes K,
Dallas S and
Chen D
(2001)
Cytokines and bone remodeling. In:
Marcus R,
Feldman D and
Kelsey J (eds)
Osteoporosis,
2nd edn, vol. 1,
pp. 373–404.
San Diego, CA:
Academic Press.
Orwoll ES and
Klein RF
(2001)
Osteoporosis in men: epidemiology, pathophysiology, and clinical characterization. In:
Marcus R,
Feldman D and
Kelsey J (eds)
Osteoporosis,
2nd edn, vol. 2,
pp. 103–150.
San Diego, CA:
Academic Press.
Riggs BL,
Khosla S and
Melton LJ 3rd
(2002)
Sex steroids and the construction and conservation of the adult skeleton.
Endocrine Reviews
23: 279–302.
Rizzoli R,
Bonjour JP and
Ferrari SL
(2001)
Osteoporosis, genetics and hormones.
Journal of Molecular Endocrinology
26: 79–94.
Robling AG,
Castillo AB and
Turner CH
(2006)
Biomechanical and molecular regulation of bone remodeling.
Annual Review of Biomedical Engineering
8: 455–498.
Rosen CJ
(2005)
Postmenopausal osteoporosis.
New England Journal of Medicine
353(6): 595–603.
Rossouw JE,
Anderson GL,
Prentice RL et al.
(2002)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.
Journal of American Medical Association
288: 321–333.
Sowers MR,
Jannausch M,
McConnell D et al.
(2006)
Hormone predictors of bone mineral density changes during the menopausal transition.
Journal of Clinical Endocrinology and Metabolism
91: 1261–1267.
Further Reading
Abu‐Amer Y
(2005)
Advances in osteoclast differentiation and function.
Current Drug Targets. Immune, Endocrine and Metabolic Disorders
5(3): 347–355.
Balemans W,
Van Wesenbeeck L and
Van Hul W
(2005)
A clinical and molecular overview of the human osteopetroses.
Calcified Tissue International
77(5): 263–274.
Eisman JA
(2006)
Genetics of osteoporosis. In:
Favus MJ (ed.)
Osteoporosis, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism,
6th edn,
pp. 249–254.
Washington, DC:
ASBMR Press.
Ferrari SL and
Rizzoli R
(2005)
Gene variants for osteoporosis and their pleiotropic effects in aging.
Molecular Aspects of Medicine
26: 145–167.
Fitzpatrick LA
(2002)
Secondary causes of osteoporosis.
Mayo Clinic Proceedings
77: 453–468.
Heaney RP
(2001)
Nutrition and risk for osteoporosis. In:
Marcus R,
Feldman D and
Kelsey J (eds)
Osteoporosis,
2nd edn, vol. 1,
pp. 669–700.
San Diego, CA:
Academic Press.
Hoff A,
Cote GJ and
Gagel RF
(2001)
Calcitonin. In:
Marcus R,
Feldman D and
Kelsey J (eds)
Osteoporosis,
2nd edn, vol. 1,
pp. 247–256.
San Diego, CA:
Academic Press.
Hochberg MC
(1998)
Bisphosphonates. In:
Cumming SR,
Cosman F and
Jama SA (eds)
Osteoporosis: An Evidence‐based Guide to Prevention and Management,
pp. 181–195.
Philadelphia, PA:
American College of Physicians.
Jiang Y,
Zhao JJ,
Mitlak BH et al.
(2003)
Recombinant human parathyroid hormone (1–34) improves both cortical and cancellous bone structure.
Journal of Bone and Mineral Research
18: 1932–1941.
Jin H and
Ralston SH
(2005)
Genetics of osteoporosis.
Current Rheumatology Reports
7: 66–70.
Johnell O,
Gullberg B,
Kanis JA et al.
(1995)
Risk factors for hip fracture in European women: The MEDOS study. Mediterranean Osteoporosis Study.
Journal of Bone and Mineral Research
10: 1802–1815.
Kanis JA
(2003)
Diagnosis of osteoporosis and assessment of fracture risk.
Lancet
359: 1929–1936.
Liedert A,
Kaspar D,
Blakytny R,
Claes L and
Ignatius A
(2006)
Signal transduction pathways involved in mechanotransduction in bone cells.
Biochemical and Biophysical Research Communications
349: 1–5.
Llorens R
(2006)
A review of osteoporosis: diagnosis and treatment.
Missouri Medicine
103: 612–615; quiz 615–616.
Melton LJ and
Cooper C
(2001)
Magnitude and impact of osteoporosis and fractures. In:
Marcus R,
Feldman D and
Kelsey J (eds)
Osteoporosis,
2nd edn, vol. 1,
pp. 557–567.
San Diego, CA:
Academic Press.
Michaelson K,
Melhus H,
Ferm H,
Ahlbom A and
Pedersen NL
(2005)
Genetic liability to fractures in the elderly.
Archives of Internal Medicine
165: 1825–1830.
National Osteoporosis Foundation
(2003)
Physician's Guide to Prevention and Treatment of Osteoporosis.
Belle Mead, NJ:
Excerpta Medica.
Neer RM,
Arnaud CD,
Zanchetta JR et al.
(2001)
Effect of parathyroid hormone (1‐34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
New England Journal of Medicine
344: 1434–1441.
Orwoll ES
(2003)
Men, bone and estrogen: unresolved issues.
Osteoporosis International
14: 93–98.
Parfitt M
(2002)
PTH and periosteal bone expansion.
Journal of Bone and Mineral Research
17: 1741–1743.
Prentice A,
Schoenmakers I,
Laskey MA et al.
(2006)
Nutrition and bone growth and development.
Proceedings of the Nutrition Society
65: 348–360.
Riggs BL,
O’Fallon WM,
Muhs J et al.
(1998)
Long term effects of calcium supplementation on serum parathyroid hormone levels, bone turnover, and bone loss in elderly women.
Journal of Bone and Mineral Research
13: 168–174.
Schousboe JT,
Taylor BC and
Ensrud KE
(2006)
Assessing fracture risk: who should be screened?. In:
Favus MJ (ed.)
Osteoporosis; Primer on the Metabolic bone Diseases and Disorders of Mineral Metabolism,
6th edn,
pp. 262–267.
Washington, DC:
ASBMR Press.
Tolar J,
Teitelbaum SL and
Orchard PJ
(2004)
Osteopetrosis.
New England Journal of Medicine
351(27): 2839–2849.
World Health Organization Study Group
(1994)
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis.
Geneva, Switzerland:
World Health Organization.
Wren TA and
Gilsanz V
(2006)
Assessing bone mass in children and adolescents.
Current Osteoporosis Reports
4: 153–158.
Wren TA,
Liu X,
Pitukcheewanont P and
Gilsanz V
(2005)
Bone acquisition in healthy children and adolescents: comparisons of dual‐energy X‐ray absorptiometry and computed tomography measures.
Journal of Clinical Endocrinology and Metabolism
90: 1925–1928.